COVID19 treatment | e-Asfalistiki

Germany: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment

European Investment Bank and Atriva Therapeutics sign financing agreement of €24 million for the research, development and clinical testing of the company’s lead product candidate against influenza and COVID-19 Atriva’s…

Videos

  • 19th Hydra Meeting 2017 - 9

    • 19th Hydra Meeting 2017 - 9

    • Watch Video

  • 19th Hydra Meeting 2017 - 6

    • 19th Hydra Meeting 2017 - 6

    • Watch Video

  • 19th Hydra Meeting 2017 - 4

    • 19th Hydra Meeting 2017 - 4

    • Watch Video

  • 19th Hydra Meeting 2017 - 2

    • 19th Hydra Meeting 2017 - 2

    • Watch Video

Tα cookies μας βοηθούν να σας παρέχουμε καλύτερες υπηρεσίες. Χρησιμοποιώντας τις υπηρεσίες μας συμφωνείτε στη χρήση των cookies.
Ok